New genetic test may uncover hidden nerve disease in patients with unexplained symptoms

NCT ID NCT03720275

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new genetic screening approach to find cases of a rare inherited nerve disease called TTR-FAP in 130 patients with chronic neuropathy of unknown cause. The goal was to see how many of these patients actually have TTR-FAP, which is often missed due to varied symptoms. By using a simple blood test to look for TTR gene mutations, researchers hope to speed up diagnosis and allow earlier treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AMYLOID NEUROPATHIES, FAMILIAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Reference center for neuromuscular diseases

    Bordeaux, 33076, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.